Targets for Anti-HIV-1 Agents as Personalized HIV Therapy: A Review Study
Volume 8, Issue 30, Summer 2023, Pages 25-31
https://doi.org/10.22034/pmj.2023.2011750.1016
Mina Jafari, Ava Shamipak, Fateme Shahsavari, Armin Nikdehqan, Paniz Hajihossein
Abstract The enormous genetic variety of the viral population harbored by the patient and the large volume of therapeutic alternatives characterize HIV therapy. Each patient and period has its viral population. The enormous number of therapy possibilities makes selecting an ideal or near-optimal therapy challenging, especially among therapy-experienced patients. Over the last decade, computer-based medication selection that measures viral resistance to pharmaceuticals has become a norm for HIV patients. We explore the qualities of available systems and the field's viewpoints.